Azithromycin Treatment for Typhoid Fever

Evidence-Based Dosing Recommendations

The American College of Physicians recommends azithromycin 500 mg once daily on day 1, followed by 500 mg once daily for 6 more days (total 7 days) for adults with typhoid fever 1
For quinolone-resistant typhoid, the Infectious Diseases Society of America recommends azithromycin as the preferred treatment option 2, 3
A single 1-gram dose or 500 mg daily for 3 days of azithromycin has been shown effective for some enteric infections, but the 7-day course is preferred for typhoid fever, according to the Centers for Disease Control and Prevention 4

Azithromycin demonstrates superior efficacy compared to fluoroquinolones for treating typhoid fever, especially in areas with high rates of fluoroquinolone resistance, with a lower risk of clinical failure (OR 0.48) and shorter hospital stay, as reported by the Clinical Microbiology and Infection journal 3
Azithromycin has a lower risk of relapse (OR 0.09) compared to ceftriaxone, according to the Clinical Microbiology and Infection journal 3

Azithromycin is particularly effective against quinolone-resistant Salmonella typhi strains, and should be considered first-line for suspected or confirmed quinolone-resistant typhoid fever, as recommended by the World Health Organization 2, 1, 3

Azithromycin is generally well-tolerated with minimal side effects, with the most common adverse effects being gastrointestinal: nausea, vomiting, abdominal pain, diarrhea, as reported by the MMWR Recommendations and Reports journal 4, 5
The Centers for Disease Control and Prevention recommend monitoring for potential drug interactions, particularly with agents metabolized by cytochrome P450 enzyme system, and contraindicate azithromycin in patients with history of hypersensitivity to any macrolide agent 5

If poor response to azithromycin occurs, the Infectious Diseases Society of America recommends considering confirming antimicrobial susceptibility testing if available, switching to a third-generation cephalosporin (e.g., ceftriaxone), or combination therapy with cefixime, as reported by the Clinical Microbiology and Infection journal 2, 3